CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- Open-market buys, last 90 days
- $9,705
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,705. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-18 | TWOMEY CHRISTOPHER J Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-06-18 | Linney Yvonne Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-06-03 | OLDAKOWSKI MARK CHIEF OPERATING OFFICER | Grant or award | +16,000 | 64,698 | ||
| 2024-06-03 | OLDAKOWSKI MARK CHIEF OPERATING OFFICER | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-06-03 | Kama Gulsen Chief Financial Officer | Grant or award | +16,000 | 16,000 | ||
| 2024-06-03 | Kama Gulsen Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-06-03 | Holmlin R. Erik PRESIDENT AND CEO | Grant or award | +44,000 | 121,813 | ||
| 2024-06-03 | Holmlin R. Erik PRESIDENT AND CEO | Grant or award · Stock Option (Right to Buy) | +204,000 | 204,000 | ||
| 2024-06-03 | Dixon Jonathan V. GENERAL COUNSEL | Grant or award | +14,500 | 18,025 | ||
| 2024-06-03 | Dixon Jonathan V. GENERAL COUNSEL | Grant or award · Stock Option (Right to Buy) | +68,000 | 68,000 | ||
| 2024-06-03 | Chaubey Alka CHIEF MEDICAL OFFICER | Grant or award | +16,000 | 48,245 | ||
| 2024-06-03 | Chaubey Alka CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-02-15 | Chaubey Alka CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,081 | $1.27 | $1K | 31,487 |
| 2024-02-15 | OLDAKOWSKI MARK CHIEF OPERATING OFFICER | Shares withheld for taxes | −1,229 | $1.27 | $2K | 48,644 |
| 2024-02-15 | Holmlin R. Erik PRESIDENT AND CEO | Shares withheld for taxes | −3,073 | $1.27 | $4K | 77,663 |
| 2024-02-15 | Dixon Jonathan V. GENERAL COUNSEL | Shares withheld for taxes | −402 | $1.27 | $511 | 3,525 |
| 2023-09-18 | OLDAKOWSKI MARK Chief Operating Officer | Grant or award | +20,000 | 317,842 | ||
| 2023-09-18 | OLDAKOWSKI MARK Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-09-18 | Chaubey Alka Chief Medical Officer | Grant or award | +20,000 | 144,794 | ||
| 2023-09-18 | Chaubey Alka Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 |
Page 4 of 14 · 266 trades